Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy
The tumor suppressor p53 is believed to be the mostly studied molecule in modern biomedical research. Although p53 interacts with hundreds of molecules to exert its biological functions, there are only a few modulators regulating its expression and function, with murine double minute 2 (MDM2) playin...
Main Authors: | Wei Wang, Atif Zafar, Mehrdad Rajaei, Ruiwen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1176 |
Similar Items
-
Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
by: Jiang-Jiang Qin, et al.
Published: (2017-12-01) -
Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach
by: Keting Li, et al.
Published: (2024-12-01) -
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
by: Haohao Zhu, et al.
Published: (2022-07-01) -
Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action
by: Wei Wang, et al.
Published: (2020-12-01) -
Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action
by: Surendra R. Punganuru, et al.
Published: (2020-07-01)